Risk factors associated with cisplatin‐induced ototoxicity in Japanese patients with solid tumors
Abstract Background Cisplatin, a first‐generation platinum agent, is used for managing various cancers and is associated with dose‐dependent side effects of hearing impairment and tinnitus. However, the safety of high‐dose cisplatin in hearing impairment, has not been fully investigated in Japan. Me...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-04-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.5565 |